Clinical Trial: A Study of Volrustomig in Women With High Risk Locally Advanced Cervical Cancer (IVOLGA)

U.S., April 25 -- ClinicalTrials.gov registry received information related to the study (NCT06943833) titled 'A Study of Volrustomig in Women With High Risk Locally Advanced Cervical Cancer (IVOLGA)' on March 11.

Brief Summary: This is a phase II single-arm open-label study to investigate the efficacy and safety of volrustomig in women with FIGO 2018 stage IIIA to IVA cervical cancer who have not progressed following platinum-based concurrent chemoradiation therapy (CCRT).

Study Start Date: March 31

Study Type: INTERVENTIONAL

Condition: Locally Advanced Cervical Cancer

Intervention: BIOLOGICAL: Volrustomig

IV infusion

Recruitment Status: RECRUITING

Sponsor: AstraZeneca

Published by HT Digital Content Services with permission from...